Results 111 to 120 of about 62,143 (212)

A phase 1 study of berzosertib (M6620, VX‐970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

Cancer, Volume 132, Issue 6, 15 March 2026.
ABSTRACT Background Ataxia telangiectasia Rad3‐related (ATR) protein kinase regulates DNA damage response and is essential for tumor cell survival. Preclinically, ATR inhibition can sensitize tumor cells to radiation and chemotherapy. The authors conducted a phase 1 trial of berzosertib, a selective ATR inhibitor, in combination with definitive ...
Aarti Bhatia, Zhengjia Chen, Yuji Zhang, Justine Yang Bruce, Susanne Arnold, Varinder Kaur, Jonathan W. Riess, Moon Fenton, Barbara Burtness, Nabil F. Saba, Harold Tara, Conor E. Steuer, Dong M. Shin, Garrett Wasp, Thomas H. Davis, Malini Patel, John C. Schmitz, Priyanka Bhateja, Virginia Diavolitsis, Dan P. Zandberg, Darrion L. Mitchell, Brian F. Kiesel, Charles Kunos, Steven D. Gore, Michael Carducci, Jan H. Beumer, Taofeek K. Owonikoko   +26 more
wiley   +1 more source

Durvalumab combined with concurrent chemoradiotherapy in patients with limited‐stage small cell lung cancer: A prospective, single‐arm, phase 2 clinical trial

Cancer, Volume 132, Issue 6, 15 March 2026.
Abstract Background The current standard treatment for limited‐stage small cell lung cancer (LS‐SCLC) is concurrent chemoradiotherapy (cCRT) plus consolidation immunotherapy, with or without prophylactic cranial irradiation (PCI). However, it remains unknown whether administering immunotherapy concurrently with chemoradiotherapy confers additional ...
Chunyang Song, Xiaohan Zhao, Shuguang Li, Xuehan Guo, Xueyuan Zhang, Xiaobin Wang, Youmei Li, Ke Yan, Jingwei Su, Jinrui Xu, Shuchai Zhu, Wenbin Shen   +11 more
wiley   +1 more source

Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus [PDF]

, 2017
Cardenas, Michael L, DeWees, Todd A, Markovina, Stephanie, Mazur, Thomas R, Olsen, Jeffrey R, Parikh, Parag J, Spencer, Christopher R, Weiner, Ashley A   +7 more
core   +2 more sources

Cost-effectiveness analysis of intensity modulated radiation therapy versus robot-assisted radical prostatectomy for patients with low-risk prostate cancer in Japan. [PDF]

J Radiat Res
Igarashi A, Jingu K, Ito K, Koba R, Lee DW.   +4 more
europepmc   +1 more source

The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial. [PDF]

Cancer Res Commun
Weidhaas JB, Harris J, Gillison ML, Blakaj D, Krempl GA, Higgins K, Phan J, Dunlap NE, Mahamood ST, Dorth J, Caudell JJ, Desai AB, Galloway TJ, Pennington JD, Currey A, Lathrop J, Torres-Saavedra PA, Hayes DN, Yom SS, Le QT.   +19 more
europepmc   +1 more source

Dosimetric comparison of IMRT and VMAT with deep inspiration breath hold or free breathing for right-sided whole breast irradiation. [PDF]

BMC Cancer
Lee SF, Cokelek M, Yip PL, Bayley K, Moorfoot P, Le-Nguyen S, Phung C, Tacey M, Zissiadis Y, Chao M.   +9 more
europepmc   +1 more source

From data to treatment plan: An AI-driven path for automated breast radiotherapy planning. [PDF]

J Appl Clin Med Phys
Gallego P, Ambroa E, Pérez-Alija J, Julià JC, Jornet N, Matas A, Anson C, Mera A, Tejedor N, Vivancos H, Ruiz A, Barceló M, Dominguez A, Riu V, Roda J, Carrasco P, Balocco S, Díaz O.   +17 more
europepmc   +1 more source

Geographic access to radiotherapy facilities in Japan. [PDF]

J Radiat Res
Koike Y, Nakamura S, Numasaki H, Tanigawa N.   +3 more
europepmc   +1 more source

Etiological Factors and Development of a Predictive Model for Urinary Tract Infections in Cervical Cancer Patients Undergoing Intensity-Modulated Radiotherapy

Infection and Drug Resistance
Ying Yao,1,* Lijun Tao,1,* Li Ma,2 Yuhan Fan,3 Dongju Zheng,2 Jian Wang,1 Wen Chen1 1Department of Pharmacy, People’s Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of China ...
Yao Y, Tao L, Ma L, Fan Y, Zheng D, Wang J, Chen W   +6 more
doaj  

Dose and normal tissue complication probability analysis of various radiotherapy regimens for thymomas. [PDF]

Front Oncol
Xiandong W, Haifeng L, Wang Z, Chao L, Yan H, Jingjing L.   +5 more
europepmc   +1 more source